Skip to main content

Find Clinical Trials

Home
Conditions
Respiration Disorders

Clinical trial condition

Respiration Disorders

Explore clinical trials studying Respiration Disorders. Study availability and eligibility vary by location and protocol.

268 public trials 36 recruiting studies

Refine in advanced search Browse all conditions

Respiration Disorders trial results

Completed

Effects of Lipoic Acid on Oxidative, Inflammatory and Functional Markers in Asthmatic Patients

NCT01221350

Conditions: Allergic Rhinitis, Asthma, Bronchial Diseases, +12 more
Locations: Hospital Civil de Guadalajara "Juan I. Menchaca" Guadalajara, Jalisco, Mexico

Departamento de Fisiología, CUCS, UdeG Guadalajara, Jalisco, Mexico

View Trial Details

Completed

SCOPE-Study: Salzburg Chronic Obstructive Pulmonary Disease- Exercise and Oxygen Study

NCT01150383

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +7 more
Locations: Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University Salzburg Salzburg, Austria

View Trial Details

Completed

Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)

NCT01395862

Conditions: Respiration Disorders, Respiratory Disorders, Respiratory Tract Diseases
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults

NCT01302990

Conditions: Flu, Infections, Influenza, Human, +6 more
Locations: Accelovance Rockville, Maryland, United States

View Trial Details

Completed

Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers

NCT01690949

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +8 more
Locations: Fraunhofer Institut fur Toxicologie und Experimentelle Medicine (ITEM) Hanover, Germany

View Trial Details

Completed

Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01054170

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +15 more
Locations: Research Site Kingston, Ontario, Canada

Research Site Québec, Quebec, Canada

Research Site Hellerup, Denmark

Research Site Hvidovre, Denmark

View Trial Details

Completed

Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/Formoterol

NCT01023516

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +15 more
Locations: Research Site Lovech, Bulgaria

Research Site Pleven, Bulgaria

Research Site Plovdiv, Bulgaria

Research Site Rousse, Bulgaria

View all 66 locations

View Trial Details

Completed

A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium

NCT00949975

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +15 more
Locations: Research Site Fullerton, California, United States

Research Site Valparaiso, Indiana, United States

Research Site Council Bluffs, Iowa, United States

Research Site Hickory, North Carolina, United States

View all 105 locations

View Trial Details

Completed

Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic Obstruct

NCT01426893

Conditions: Asthma, Asthma,, Bronchial Diseases, +14 more
Locations: Research Site Belgrade, Serbia

Research Site Kamenitz, Serbia

Research Site Kragujevac, Serbia

Research Site Niš, Serbia

View Trial Details

Completed

A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00703391

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +15 more
Locations: Research Site Berlin, Germany

View Trial Details